Latest Generic drug Stories
Bernstein Liebhard LLP is currently representing testosterone lawsuit plaintiffs who have filed claims in the federal proceeding. New York, New York (PRWEB)
India has emerged as a major market for the consumption as well as manufacturing of generic medicines KUALA LUMPUR, Malaysia, April 20, 2015 /PRNewswire/ -- Fewer blockbusters drugs are expected
POTTERS BAR, England and PITTSBURGH, April 17, 2015 /PRNewswire/ -- Mylan N.V.
Biosimilars Council Releases First Biosimilars Handbook for U.S.
Bernstein Liebhard LLP Supports the Take Justice Back Campaign petition, so that Generic Drug Makers can be held Accountable for Inadequate Labeling New York,
DUBLIN, April 14, 2015 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/rtp6vz/global_cancer) has announced the addition of the "Global
POTTERS BAR, England, April 13, 2015 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced that its subsidiaries Mylan Inc. and Mylan Pharmaceuticals Inc.
CE Class Focuses on Fundamentals of Biosimilars EAST ELMHURST, N.Y., March 16, 2015 /PRNewswire/ -- With the U.S.
DUBLIN, March 12, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the United States Court of Appeals for the Federal Circuit has granted AstraZeneca's request for an injunction
- An armed gangster.